GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (FRA:GNJC) » Definitions » Effective Interest Rate on Debt %

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Effective Interest Rate on Debt % : 5.41% (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Skystar Bio-Pharmaceutical Co's annualized positive value of Interest Expense for the quarter that ended in Sep. 2014 was €0.78 Mil. Skystar Bio-Pharmaceutical Co's average total debt for the quarter that ended in Sep. 2014 was €14.50 Mil. Therefore, Skystar Bio-Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2014 was 5.41%.


Skystar Bio-Pharmaceutical Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Effective Interest Rate on Debt % Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.23 3.69 2.71 11.72 7.38

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.83 1.73 3.71 4.43 5.41

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt %

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt % falls into.



Skystar Bio-Pharmaceutical Co Effective Interest Rate on Debt % Calculation

Skystar Bio-Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2013 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2012 )+Total Debt  (A: Dec. 2013 ))/ count )
=-1  *  -0.447/( (4.354+7.768)/ 2 )
=-1  *  -0.447/6.061
=7.38 %

where

Total Debt  (A: Dec. 2012 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.968 + 3.386
=4.354

Skystar Bio-Pharmaceutical Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2014 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2014 )+Total Debt  (Q: Sep. 2014 ))/ count )
=-1  *  -0.784/( (14.113+14.88)/ 2 )
=-1  *  -0.784/14.4965
=5.41 %

where

Total Debt  (Q: Jun. 2014 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 14.113
=14.113

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2014) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Skystar Bio-Pharmaceutical Co  (FRA:GNJC) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Skystar Bio-Pharmaceutical Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (FRA:GNJC) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (FRA:GNJC) Headlines

No Headlines